Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 6 of 6 entries
View as:

A Safety and Efficacy Study Evaluating CS-101 in Subjects With β-Thalassemia Major

Phase: N/A Priority: Normal
NCT ID: NCT06291961 Org: User:
Start: 04/18/24 End: 07/31/25 Due: 07/31/26

CS-101 in Patients With β-thalassemia

Phase: N/A Priority: Normal
NCT ID: NCT06328764 Org: User:
Start: 03/19/24 End: 01/30/26 Due: 01/30/27

A Clinical Study Evaluating the Safety and Efficacy of CS-101 in Treating Subjects With β-thalassemia

Phase: N/A Priority: Normal
NCT ID: NCT06024876 Org: User:
Start: 08/26/23 End: 06/30/25 Due: 06/30/26

A Follow-up Study to Evaluate the Long-term Safety and Efficacy in Participants Who Received CS-101 Injection

Phase: N/A Priority: Normal
NCT ID: NCT06717932 Org: User:
Start: 05/31/25 End: 11/30/39 Due: 11/30/40

CS-206 in Patients With Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT06565026 Org: User:
Start: 09/02/24 End: 06/30/27 Due: 06/30/28

A Long-term Follow-up Study in Participants Who Received CS-101

Phase: N/A Priority: Normal
NCT ID: NCT06685536 Org: User:
Start: 01/18/25 End: 07/31/39 Due: 07/31/40